The three vaccines, incidentally, have the highest stated efficacy during phase 3 trials at 95, 94, and 92 percent, respectively. Bias for Pfizer-BioNTechFilipinos, judging from the exuberant local reception to the Pfizer-BioNTech vaccine, will opt to be “choosy,” knowing too well that all COVID-19 vaccines now being rolled out took a shortcut route, hence the need for them to sign indemnity waivers when getting a shot. The vaccines from Pfizer-BioNTech and Moderna now command a premium in pricing, having exhibited a high safety record. Supply price contracts between governments and COVID-19 vaccine manufacturers continue to be kept confidential, but information leaks have shown how expensive they are. Still, people are looking forward to lining up for a Pfizer-BioNTech or Moderna jab, even if it means paying for it.

Source: Philippine Star May 19, 2021 15:56 UTC